Hartland’s H&P recalls more products
A Hartland pharmaceutical company, already under heavy scrutiny by the U.S. Food and Drug Administration, has initiated a recall of several of its products at the request of the government agency. (MILWAUKEE BUSINESS JOURNAL, 8/26)
To access this content, you must purchase a Premium membership, or log in if you are a member.
